COVID-19 in multiple sclerosis:The Dutch experience
Here, we provide an extensive overview of all reported COVID-19 cases in multiple sclerosis (MS) patients in the Netherlands between 27 February and 9 June 2020, gathered by the Dutch MS Taskforce of the Netherlands Society of Neurology. A total of 86 MS patients were reported, 43 of whom tested positive for COVID-19. Of 43 patients who tested positive, 22 patients were hospitalized. Three intensive care unit (ICU) admissions and four deaths were reported. Our findings show no apparent difference in disease-modifying treatment (DMT) use and COVID-19 disease course in Dutch MS patients. In addi... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2020 |
| Reihe/Periodikum: | Loonstra , F C , Hoitsma , E , van Kempen , Z L E , Killestein , J & Mostert , J P 2020 , ' COVID-19 in multiple sclerosis : The Dutch experience ' , Multiple Sclerosis Journal , vol. 26 , no. 10 , pp. 1256-1260 . https://doi.org/10.1177/1352458520942198 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-29047999 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://research.vumc.nl/en/publications/4a9a6f75-94bb-4186-be44-5a755bc3cdf3 |
Here, we provide an extensive overview of all reported COVID-19 cases in multiple sclerosis (MS) patients in the Netherlands between 27 February and 9 June 2020, gathered by the Dutch MS Taskforce of the Netherlands Society of Neurology. A total of 86 MS patients were reported, 43 of whom tested positive for COVID-19. Of 43 patients who tested positive, 22 patients were hospitalized. Three intensive care unit (ICU) admissions and four deaths were reported. Our findings show no apparent difference in disease-modifying treatment (DMT) use and COVID-19 disease course in Dutch MS patients. In addition, a clear link between low lymphocyte count and severe disease was not observed.